| 2025-11-13 |
详情>>
股本变动：
变动后总股本3980.25万股
|
| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.30美元,归母净利润5404.10万美元,同比去年增长709.19%
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益0.14美元,归母净利润564.60万美元,同比去年增长-47.47%
|
| 2025-07-16 |
股东大会：
将于2025-08-19召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited (the “Independent Auditors”), as the independent registered public accounting firm of the Company for the 2025 fiscal year;
3.To consider and approve an amendment to the Company’s Amended and Restated 2019 Stock Incentive Plan (the “2019 Plan”);
4.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2025-07-16 |
股东大会：
将于2025-08-19召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited (the “Independent Auditors”), as the independent registered public accounting firm of the Company for the 2025 fiscal year;
3.To consider and approve an amendment to the Company’s Amended and Restated 2019 Stock Incentive Plan (the “2019 Plan”);
4.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2025-06-05 |
详情>>
内部人交易：
Sank Leonard等共交易10笔
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.19美元,归母净利润-764.2万美元,同比去年增长-597.53%
|
| 2025-03-27 |
详情>>
业绩披露：
2024年年报每股收益-0.48美元,归母净利润-1906万美元,同比去年增长-444.98%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.22美元,归母净利润-887.1万美元,同比去年增长-13.57%
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益0.26美元,归母净利润1074.80万美元,同比去年增长334.21%
|
| 2024-06-20 |
股东大会：
将于2024-08-01召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To consider and approve, by a non-binding advisory vote, the compensation of our Named Executive Officers as described in the accompanying proxy statement;
3.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited (the “Independent Auditors”), as the independent registered public accounting firm of the Company for the 2024 fiscal year;
4.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2024-06-20 |
股东大会：
将于2024-08-01召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To consider and approve, by a non-binding advisory vote, the compensation of our Named Executive Officers as described in the accompanying proxy statement;
3.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited (the “Independent Auditors”), as the independent registered public accounting firm of the Company for the 2024 fiscal year;
4.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益0.04美元,归母净利润153.60万美元,同比去年增长145.24%
|
| 2024-03-06 |
复牌提示：
2024-03-06 09:30:40 停牌，复牌日期 2024-03-06 09:35:40
|
| 2024-03-06 |
详情>>
业绩披露：
2023年年报每股收益0.14美元,归母净利润552.50万美元,同比去年增长115.11%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.19美元,归母净利润-781.1万美元,同比去年增长72.12%
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益-0.11美元,归母净利润-458.9万美元,同比去年增长78.10%
|
| 2023-05-31 |
股东大会：
将于2023-07-13召开股东大会
会议内容 ▼▲
- 1.To re-elect six directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited (the “Independent Auditors”), as the independent registered public accounting firm of the Company for the 2023 fiscal year;
3.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2023-05-31 |
股东大会：
将于2023-07-13召开股东大会
会议内容 ▼▲
- 1.To re-elect six directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited (the “Independent Auditors”), as the independent registered public accounting firm of the Company for the 2023 fiscal year;
3.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2022-06-02 |
股东大会：
将于2022-06-30召开股东大会
会议内容 ▼▲
- 1.To re-elect five directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To consider and approve, by a non-binding advisory vote, the compensation of our Named Executive Officers as described in the accompanying proxy statement;
3.To consider and approve an amendment to the Company’s Amended and Restated 2019 Stock Incentive Plan (the “2019 Incentive Plan”);
4.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited (the “Independent Auditors”), as the independent registered public accounting firm of the Company for the 2022 fiscal year;
5.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-28 |
股东大会：
将于2021-08-30召开股东大会
会议内容 ▼▲
- 1.To re-elect six directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To ratify the prior approval of the Company’s 2019 Stock Incentive Plan (the “2019 Incentive Plan”), which was adopted at the Company’s annual meeting of stockholders for the fiscal year ended August 31, 2019 (the “2019 Annual Meeting of Stockholders”);
3.To ratify the prior approval of the Company’s Amended and Restated 2019 Stock Incentive Plan (the “Amended and Restated 2019 Incentive Plan”), which was adopted at the Company’s annual meeting of stockholders for the fiscal year ended August 31, 2020 (the “2020 Annual Meeting of Stockholders”);
4.To ratify the re-election of Aviad Friedman, Xiaoming Gao, Miriam Kidron, Nadav Kidron, Arie Mayer, Kevin Rakin and Leonard Sank as directors of the Company, who were re-elected at the 2020 Annual Meeting of Stockholders;
5.To approve an amendment to the Company’s Articles of Incorporation (as amended to date, the “Charter”) in order to implement a staggered board structure;
6.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2020-06-30 |
股东大会：
将于2020-08-03召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To approve the Company’s Amended and Restated 2019 Stock Incentive Plan;
3.To approve an amendment to the Company’s Certificate of Incorporation to increase the Company’s authorized common stock from 30,000,000 shares to 60,000,000 shares;
4.To consider and approve, by a nonbinding advisory vote, the compensation of our Named Executive Officers as described in the accompanying proxy statement;
5.To recommend, by a nonbinding advisory vote, the frequency (every one, two or three years) of future advisory votes of stockholders on the compensation of our Named Executive Officers;
6.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited, as the independent registered public accounting firm of the Company for the 2020 fiscal year;
7.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2019-08-06 |
股东大会：
将于2019-08-29召开股东大会
会议内容 ▼▲
- 1.To re-elect six directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To approve the Company’s 2019 Stock Incentive Plan;
3.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited, as the independent registered public accounting firm of the Company for the 2019 fiscal year;
4.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2019-08-06 |
股东大会：
将于2019-08-29召开股东大会
会议内容 ▼▲
- 1.To re-elect six directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To approve the Company’s 2019 Stock Incentive Plan;
3.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited, as the independent registered public accounting firm of the Company for the 2019 fiscal year;
4.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2018-07-30 |
股东大会：
将于2018-08-28召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To consider and approve, by a nonbinding advisory vote, the compensation of our Named Executive Officers as described in the accompanying proxy statement;
3.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited, as the independent registered public accounting firm of the Company for the 2018 fiscal year;
4.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2017-08-01 |
股东大会：
将于2017-08-30召开股东大会
会议内容 ▼▲
- 1. To re-elect seven directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2. To ratify, approve and adopt the amendment to the Company’s Certificate of Incorporation filed on July 25, 2014 to increase the Company’s authorized common stock from 16,666,667 to 30,000,000 shares;
3. To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited, as the independent registered public accounting firm of the Company for the 2017 fiscal year;
4. To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|
| 2016-08-04 |
股东大会：
将于2016-08-30召开股东大会
会议内容 ▼▲
- 1.To elect seven directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal;
2.To approve the Company’s Second Amended and Restated 2008 Stock Incentive Plan;
3.To consider and approve, by a nonbinding advisory vote, the compensation of our Named Executive Officers as described in the accompanying proxy statement;
4.To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited, as the independent registered public accounting firm of the Company for the 2016 fiscal year;
5.To transact any other business as may properly come before the Annual Meeting or any adjournments thereof.
|